Literature DB >> 19339801

Enantiomer-specific effects of albuterol on airway inflammation in healthy and asthmatic cats.

Carol R Reinero1, Cherlene Delgado, Christine Spinka, Amy E DeClue, Rajiv Dhand.   

Abstract

BACKGROUND: Racemic (R,S)-albuterol is a 1:1 mixture of an R-enantiomer which has bronchodilatory and anti-inflammatory effects, and an S-enantiomer which is associated with increased airway hyperreactivity and proinflammatory effects. Proinflammatory effects of regularly inhalated and S-albuterol have not been studied in a whole-animal model. We hypothesized that regular administration of R,S-albuterol or S-albuterol, but not R-albuterol, would induce airway inflammation in healthy and asthmatic cats.
METHODS: Six healthy and 5 experimentally asthmatic cats were randomized to receive inhaled R,S-albuterol, S-albuterol, R-albuterol, or placebo (saline) twice daily for 2 weeks, followed by a 6-week washout before crossover to the next treatment. Bronchoalveolar lavage fluid was collected for cell counts and cytokine analysis prior to and at the end of each 2-week treatment.
RESULTS: Healthy and asthmatic cats receiving R,S- and S-albuterol had higher total lavage cell numbers (p = 0.04 and p = 0.02, respectively) than those receiving R-albuterol and placebo. The number of lavage eosinophils and the TNF-alpha bioactivity was higher in asthmatic cats receiving R,S- and S-albuterol compared with those receiving the other treatments (p = 0.03 and p = 0.004, respectively). In healthy cats, the number of lavage neutrophils was higher when they received R,S- and S-albuterol compared with other treatments (p = 0.04).
CONCLUSION: Airway inflammation is induced in both healthy and asthmatic cats with regular inhalation of racemic and S-albuterol, but not with R-albuterol. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19339801     DOI: 10.1159/000210379

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  4 in total

1.  Use of a novel one-nostril mask-spacer device to evaluate airway hyperresponsiveness (AHR) in horses after chronic administration of albuterol.

Authors:  Melissa R Mazan; Kara Lascola; Susan J Bruns; Andrew M Hoffman
Journal:  Can J Vet Res       Date:  2014-07       Impact factor: 1.310

2.  beta2-agonists promote host defense against bacterial infection in primary human bronchial epithelial cells.

Authors:  Claire A Gross; Russell P Bowler; Rebecca M Green; Andrew R Weinberger; Christina Schnell; Hong Wei Chu
Journal:  BMC Pulm Med       Date:  2010-05-14       Impact factor: 3.317

Review 3.  Turning a molecule into a medicine: the development of indacaterol as a novel once-daily bronchodilator treatment for patients with COPD.

Authors:  Lorraine Murphy; Stephen Rennard; James Donohue; Mathieu Molimard; Ronald Dahl; Kai-Michael Beeh; Juergen Dederichs; Hans-Jürgen Fülle; Mark Higgins; David Young
Journal:  Drugs       Date:  2014-09       Impact factor: 9.546

4.  Noninvasive Recognition and Biomarkers of Early Allergic Asthma in Cats Using Multivariate Statistical Analysis of NMR Spectra of Exhaled Breath Condensate.

Authors:  Yan G Fulcher; Martial Fotso; Chee-Hoon Chang; Hans Rindt; Carol R Reinero; Steven R Van Doren
Journal:  PLoS One       Date:  2016-10-20       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.